Huntington's disease is the most common monogenic neurological disorder in the developed world, with an estimated prevalence of 3.5–7/100,000 in ... read more
Roche's RG6042 receives Prime designation from EMA to treat Huntington's disease
Roche’s RG6042 receives Prime designation from EMA to treat Huntington’s disease